The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1393
June 25, 2012
View Complete Issue         Table of Contents 2019 
A New Scorpion Antivenom
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A New Scorpion Antivenom
June 25, 2012 (Issue: 1393)
Anascorp (Rare Disease Therapeutics), an intravenously administered antivenom derived from horse serum, has been approved by the FDA for treatment of clinical signs of scorpion envenomation.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: A New Scorpion Antivenom
Article code: 1393c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.